-
-
Overview
-
Product Uses Include:
Determination of the activity and GTPase specificity of uncharacterized GEFs.
Biochemical characterization of small GTPases and their associated GEFs.
Examination of the regulation of GEF activity by different cofactors or protein domains.
Screen the mutant protein of either GEFs or GTPases for activity and substrate specificity.
Identification of GEF inhibitors in HTS (high throughput screen) format. Please inquire for significant discounts on large quantities of any reagents in this kit
Introduction
The Ras superfamily of small GTPases consist of more than 150 members, which based on their sequence homology, are divided into several subfamilies such as Rho, Ras, Ran, Rab, Arf and Rem/Rad families. This group of small GTPases serve as binary switches cycling between GDP-bound inactive and GTP-bound active states . The regulatory proteins for this switch include guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs). GEFs catalyze the exchange of GDP for GTP to generate the active state of small GTPases in response to extracellular signals. In order to facilitate the exchange, the GEFs must bind to the GDP-bound GTPases, destabilize the GDP-GTPase complex, and then stabilize a nucleotide-free reaction intermediate. Because of the high intracellular ratio of GTP to GDP, the released GDP is replaced with GTP, leading to release of GEFs from the complex and activation of the GTPase. Many GEF proteins have been identified as oncogenes and are involved in human diseases such as cancer. Interestingly, the expression of GEF protein is tissue- or cell-type specific, providing a therapeutic potential for cancer treatment. Recently developed fluorescence analogs of guanine nucleotides have greatly improved the technical ability to define the real-time exchange reaction of GEFs, including kinetic and thermodynamic properties, thereby eliminating the need for traditional radioactive labeling methods. This fluorescence-based assay takes advantage of the spectroscopic difference between bound and unbound fluorescent analogs to guanine nucleotides and resulting in the ability to monitor nucleotide exchange of small GTPases. Once bound to GTPases, the emission intensity of the fluorophore increases dramatically. Therefore, the enhancement of fluorescent intensity in the presence of small GTPases and GEFs will reflect the respective GEF activities of known or unknown proteins. Cytoskeleton Inc. has developed a N-MAR-GTP fluorophore-based Rho-GEF assay suitable for both 96-well and 384-well formats. This assay can be applied to multiple research purposes such as characterizing the GEFs and identifying GEF inhibitors in a high-throughput screen format. This kit contains human Cdc42, Rac1 and RhoA proteins and the GEF domain of Dbs as a positive control GEF for Cdc42 and RhoA. Dbs shows extremely low GEF activity for Rac1. Interestingly, it was reported that human Dbs can activate Rac1 in a FRET-based assay.
References
1) Shielge, J. M., et al. Trend Cell Biol., 2000, 10, 147-54.
2) Whitehead, I. P., et al. Biochim. Biophys. Acta, 1997, 1332, F1-23.
3) Zheng, Y. Trend Biochem Sci.2002. 26, 724-32.
4) Cheng, L., et al. Mol. Cell. Biol. 2002. 22, 6895-6905.
5) Rossman, K. L., et al. Embo J. 2002. 21, 1315-1326.
6) McEwen, D.P., et al. Anal. Biochem. 2001. 291, 109-117.
7) Whitehead, I. P., et al. Mol. Cell. Biol. 1999. 19, 7759-7770.
8) Itoh, R. E., et al. Mol. Cell. Biol. 2002. 22, 6582-6591.
9) Manor, D. Methods Enzymol. 2000. 325, 139-149.Please contact us at for specific academic pricing.
-
- Properties
- Reference
-
Overview